Literature DB >> 35890335

Editorial: Special Issue Development of Micro and Nano Systems for the Drug Delivery.

Giovanna Della Porta1,2.   

Abstract

In this Issue, I have collected ten research papers and four review articles trying to describe the technologies that have evolved in the past ten years for the development of micro and nano systems for drug carry, targeting and delivery [...].

Entities:  

Year:  2022        PMID: 35890335      PMCID: PMC9315868          DOI: 10.3390/pharmaceutics14071440

Source DB:  PubMed          Journal:  Pharmaceutics        ISSN: 1999-4923            Impact factor:   6.525


In this Issue, I have collected ten research papers and four review articles trying to describe the technologies that have evolved in the past ten years for the development of micro and nano systems for drug carry, targeting and delivery. The review papers included research scenarios of nano-emulsions formulations for nose-to-brain delivery, taking into account that the blood–brain barrier (BBB) is one of the major issues and limiting the drugs targeting the brain [1]; the bio-inspired and in situ self-assembly of polypeptides recently proposed for potential challenges in clinical treatment [2]; nanoparticles inducing ferroptosis for tumor targeting and immunomodulation [3]; and different nanomedicine approaches to clinical malaria [4] in order to better explain how nanoscience can contribute to achieve solutions. On the other hand, for an accurate device formulation and engineering, its size tailoring and drug encapsulation efficiency are, in several cases, still a technological challenge for the near future. In this sense, smart nano-materials and related innovative processes and technologies for their fabrication can be extremely promising for both pharmaceutical and biomedical fields. Research articles were selected to describe advanced nano-formulations for drug delivery and related fabrication technologies, such as high-energy microfluidization technique to obtain nano-emulsion with vesicles size of 200–250 nm [5], procedures to organize pH-sensitive thin films [6], protocols to obtain PEGylated liposomes [6], and superparamagnetic iron oxide nanoparticles (SPIONs) [7]. All these formulations have been reported to successfully encapsulate anticancer drugs for a more precise and better targeted delivery. From nanovesicles and nanosomes up to micro/nano advanced materials, the papers selected explored the different solutions adopted and the several approaches attempted to formulate complex micro/nano devices for active principle storage and delivery versus specific target. Advanced formulations including iron oxide mesoporous magnetic nanostructures (IO-MMNs) fabricated via new chemical synthesis [8], bio-inspired cell-derived nano-vesicles (CDNs) with unique properties in terms of binding and target cell uptake by and intrinsic biological activities [9], and nanostructured Lipid Carriers dispersions stabilized with a carbohydrate cryoprotectants [10], are all examples of innovative and nanostructures materials developed for advanced formulations. Finally, it is my opinion that the development of robust and reproducible in-vitro models is extremely important for the drug formulation pre-screening and testing. However, monolayer 2D culture are not proper usefull for the scope, whereas, 3D culture coupled with advanced bioreactor for dynamic input delivery are fundamental instruments for exploring the effectiveness of those innovative formulations. As an example, was included in the collection a study on formulation properties acquired under physiological flow using a modified plate-flow chamber. By adopting fluorescently labeled human platelets and endothelial progenitor cells (EPCs) it was possible to monitor cells response in real-time using fluorescent imaging [11]. All papers selected covered issues to explore how the research field of drug delivery and nanomedicine is evolving and what the future might bring.
  11 in total

1.  Quantitative Cryo-TEM Reveals New Structural Details of Doxil-Like PEGylated Liposomal Doxorubicin Formulation.

Authors:  Rickard Nordström; Lin Zhu; Johan Härmark; Yael Levi-Kalisman; Erez Koren; Yechezkel Barenholz; Genia Levinton; Dima Shamrakov
Journal:  Pharmaceutics       Date:  2021-01-19       Impact factor: 6.321

Review 2.  Intranasal Nanoemulsions for Direct Nose-to-Brain Delivery of Actives for CNS Disorders.

Authors:  Shiv Bahadur; Dinesh M Pardhi; Jarkko Rautio; Jessica M Rosenholm; Kamla Pathak
Journal:  Pharmaceutics       Date:  2020-12-18       Impact factor: 6.321

3.  Iron Oxide Mesoporous Magnetic Nanostructures with High Surface Area for Enhanced and Selective Drug Delivery to Metastatic Cancer Cells.

Authors:  Kheireddine El-Boubbou; Rizwan Ali; Sulaiman Al-Humaid; Alshaimaa Alhallaj; O M Lemine; Mohamed Boudjelal; Abdulmohsen AlKushi
Journal:  Pharmaceutics       Date:  2021-04-14       Impact factor: 6.321

4.  Hybrid System for Local Drug Delivery and Magnetic Hyperthermia Based on SPIONs Loaded with Doxorubicin and Epirubicin.

Authors:  Dorota Nieciecka; Joanna Celej; Michał Żuk; Agnieszka Majkowska-Pilip; Kinga Żelechowska-Matysiak; Antoni Lis; Magdalena Osial
Journal:  Pharmaceutics       Date:  2021-04-01       Impact factor: 6.321

Review 5.  Recent Progress in the Design and Medical Application of In Situ Self-Assembled Polypeptide Materials.

Authors:  Tian-Tian Wang; Yi-Yi Xia; Jian-Qing Gao; Dong-Hang Xu; Min Han
Journal:  Pharmaceutics       Date:  2021-05-19       Impact factor: 6.321

6.  The Combination of Tissue-Engineered Blood Vessel Constructs and Parallel Flow Chamber Provides a Potential Alternative to In Vivo Drug Testing Models.

Authors:  Wanjiku Njoroge; Andrea C Hernández Hernández; Faiza Idris Musa; Robert Butler; Alan G S Harper; Ying Yang
Journal:  Pharmaceutics       Date:  2021-03-05       Impact factor: 6.321

7.  Lyophilization Preserves the Intrinsic Cardioprotective Activity of Bioinspired Cell-Derived Nanovesicles.

Authors:  Yub Raj Neupane; Chenyuan Huang; Xiaoyuan Wang; Wei Heng Chng; Gopalakrishnan Venkatesan; Olga Zharkova; Matthias Gerhard Wacker; Bertrand Czarny; Gerrit Storm; Jiong-Wei Wang; Giorgia Pastorin
Journal:  Pharmaceutics       Date:  2021-07-09       Impact factor: 6.321

Review 8.  Review of the Current Landscape of the Potential of Nanotechnology for Future Malaria Diagnosis, Treatment, and Vaccination Strategies.

Authors:  Arnau Guasch-Girbau; Xavier Fernàndez-Busquets
Journal:  Pharmaceutics       Date:  2021-12-17       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.